In this episode, we dive into the WISDOM Study—a groundbreaking randomized clinical trial designed to compare personalized breast cancer screening with conventional approaches. The goal? To determine if a tailored approach can help prevent advanced breast cancer (stage IIB or higher).

The study is enrolling 100,000 women ages 30-74 across the United States. Joining me are Steffanie Goodman, who leads marketing and communications for WISDOM, and Allison Fiscalini, a study co-investigator. Together, we cover everything you need to know about WISDOM: study logistics, eligibility criteria, costs, data privacy, benefits of participation, the genetic study component, and more!

Ready to learn how this research could change breast cancer screening? Tune in to this informative discussion.

Find out more about the WISDOM study here and follow them on Instagram.